126 completed, 23 unknown, 12 not yet recruiting, 11 recruiting. 77 Not applicable, 27 Phase 2, 22 Phase 4, 21 Phase 3, 16 Phase 1.
Follow Acne: new trials by email Literature Review of Acne trials Research Report on Acne
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Role of Akkermansia Muciniphila in Acne Vulgaris Akkermansia Muciniphila, Clostridium Beijerinckii, Anaerobutyricum Hallii, Clostridium Butyricum, Bifidobacterium Infantis Probiotic Capsule - Acne | Early Phase 1 | Not yet recruiting | Medical University of South Carolina | 34 | 2027-03-01 | 2026-05-12 |
| Safety of the Acne mRNA Vaccine in Adolescents 12 to 17 Years of Age With Moderate to Severe Acne Acne mRNA (messenger ribonucleic acid) vaccine, Placebo - Acne | Phase 2 | Not yet recruiting | Sanofi | 410 | 2026-10-30 | 2026-09-18 |
| Demodex Mites in Acne Patients and Herbal Extract Susceptibility Acne, Demodex Infestation | Not yet recruiting | Assiut University | 80 | 2026-09-26 | 2026-09-28 | |
| A Randomised Controlled Trial of ePROM-Guided Flexible Scheduling in Dermatology Flexible ePROM-guided Scheduling System, electronic patient reported outcome measures (ePROMs) - Chronic Dermatological Conditions, Eczema | Not applicable | Not yet recruiting | National University Hospital, Singapore | 250 | 2026-09-01 | 2026-07-01 |
| Photodynamic Therapy With Topical Application of a Zn(II) Phthalocyanine (RLP068/Cl) and Red Light for the Treatment of Moderate-to-severe Acne Vulgaris Zn(II)-phthalocyanine gel - Acne | Not applicable | Not yet recruiting | Università degli Studi di Brescia | 10 | 2026-08-01 | 2026-05-04 |
| Clinical Observation of Skin Condition in Patients With Acne Vulgaris Using Ubiquinol, Pomegranate Peel Extract, Ceramide, and Salicylic Acid Emulsion Acne | Not yet recruiting | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 40 | 2026-07-20 | 2026-07-29 | |
| A Clinical Trial to Investigate the Efficacy and Safety of GenLabs' Social Renew on Improving Acne Symptoms and Skin Repair Among Healthy Adults Social Renew, Placebo - Acne | Not applicable | Not yet recruiting | GenCanna Acquisition Corp | 150 | 2026-07-01 | 2026-06-30 |
| Safety and Efficacy of Skincare Products for Managing Mild to Moderate Acne in Individuals With Sensitive Skin Cleanser, Toner, Serum - Acne | Not applicable | Recruiting | USMARI Research & Innovation Centre | 34 | 2026-06-01 | 2026-08-06 |
| Exploring Acne Treatments Through Clinical Research Participation Acne | Not yet recruiting | Power Life Sciences Inc. | 500 | 2026-06-01 | 2025-06-08 | |
| Skin Inflammation in (Peri)Menopause: A Probiotic Intervention Proof of Concept Trial Lactobacillus casei Shirota (LcS) Probiotic Drink, Skimmed Milk Control Drink - Skin Inflammation, Immunosenescence | Not applicable | Recruiting | King's College London | 30 | 2026-04-28 | 2026-05-08 |
| Sebum Metabolomics and Lipidomics for Clinical Applications Sebutape sampling, Bacitracin/Polymyxin B/Neomycin ointment (Yentuogin ointment) - Acne, Atopic Dermatitis | Not applicable | Not yet recruiting | National Taiwan University Hospital | 200 | 2026-04-01 | 2026-04-24 |
| Non-interventional Translational Study in Mild, Moderate and Severe Acne Patients Acne | Not yet recruiting | National Skin Centre | 200 | 2026-02-15 | 2026-02-17 | |
| Expert Consensus on the Use of Isotretinoin in Acne Vulgaris: A Delphi Study Isotretinoin, Isotretinoin Adverse Reaction | Enrolling by invitation | Venus Research Center | 15 | 2026-01-25 | 2025-12-22 | |
| Topical Application of Engineered Lactobacillus Reuteri With a Zinc Sulfate-Tannic Acid MPN Coating for Acne MPN-coated engineered Lactobacillus reuteri cream, Plain Lactobacillus reuteri cream, Petrolatum-glycerin cream - Acne | Phase 2 | Recruiting | Shenzhen People's Hospital | 196 | 2025-12-30 | 2026-04-06 |
| Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Participants With Mild Acne Acne mRNA vaccine, Placebo - Acne | Phase 1 / Phase 2 | Recruiting | Sanofi Pasteur, a Sanofi Company | 228 | 2025-07-03 | 2026-07-09 |
| An Observational Clinical Study to Evaluate the Efficacy of the CeraVe Skin Care Line CeraVe - Acne | Not yet recruiting | ChinaNorm | 240 | 2025-06-27 | 2025-06-29 | |
| PMCF Investigation of Medical Device ChitoCare® Medical ChitoCare® medical Wound Healing Gel, ChitoCare® medical Healing Spray - Dermatitis, Acne | Recruiting | Primex ehf | 214 | 2025-06-11 | 2025-08-17 | |
| Phase 1 Study to Evaluate the Safety, Tolerability, PK, and PD of TVB-3567 in Healthy Participants With or Without Acne TVB-3567, Placebo - Acne | Phase 1 | Recruiting | Sagimet Biosciences Inc. | 152 | 2025-06-03 | 2026-10-21 |
| The Suitability of Tience® for Treating Acne Scars Intradermal injections - Acne, Acne Scars | Not applicable | Active not recruiting | Linio Biotech Oy | 20 | 2025-05-01 | 2026-06-23 |
| 577-nm Diode Laser in the Treatment of Non -Inflammatory Acne 577 nm Diode laser - Acne | Not applicable | Completed | Al-Azhar University | 50 | 2025-03-29 | 2026-08-18 |
Showing 20 of 196. Sign in to see all of them.
Acne Vulgaris (196) · Psoriasis (11) · Cicatrix (9) · Dermatitis, Atopic (8) · Dermatitis (7) · Eczema (7) · Hyperpigmentation (6) · Rosacea (6) · Skin Diseases (6) · Dermatitis, Seborrheic (4) · Alopecia (3) · Hidradenitis Suppurativa (3) · Melanosis (3) · Urticaria (3) · Acne Conglobata (2)
Acneiform Eruptions (196) · Skin and Connective Tissue Diseases (196) · Sebaceous Gland Diseases (195) · Skin Diseases (190) · Pathological Conditions, Signs and Symptoms (26) · Pathologic Processes (21) · Skin Diseases, Eczematous (17) · Dermatitis (14) · Immune System Diseases (14) · Skin Diseases, Papulosquamous (14) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (12) · Hypersensitivity (12) · Hypersensitivity, Immediate (11) · Pigmentation Disorders (11) · Fibrosis (10)
Adapalene (14) · Gels (11) · Benzoyl Peroxide (10) · Tretinoin (9) · Adapalene, Benzoyl Peroxide Drug Combination (7) · Doxycycline (7) · Clindamycin (6) · Isotretinoin (5) · Salicylic Acid (4) · Minocycline (3) · clindamycin phosphate (3) · 1-phenyl-3,3-dimethyltriazene (2) · Acne RA-1,2 (2) · Carnitine (2) · Cosmetics (2)
Galderma R&D (11) · Cosmetique Active International (10) · Pierre Fabre Dermo Cosmetique (8) · Bausch Health Americas, Inc. (6) · Seoul National University Hospital (4) · Stiefel, a GSK Company (4) · AI Labs Group S.L (3) · Integrative Skin Science and Research (3) · Mahidol University (3) · Padagis LLC (3) · Sanofi Pasteur, a Sanofi Company (3) · Shahid Beheshti University of Medical Sciences (3) · Shanghai Dermatology Hospital (3) · Spear Pharmaceuticals (3) · University of California, Davis (3)
United States (87) · Canada (14) · China (13) · France (10) · Brazil (7) · South Korea (6) · Spain (6) · Egypt (4) · Iran (4) · Poland (4) · Thailand (4) · Australia (3) · Italy (3) · Mauritius (3) · United Kingdom (3)
Anya Loncaric (3) · Antonio Martorell, PhD (2) · Jim Pankovich (2) · Leon H. Kircik, M.D. (2) · Michael B Gill (2) · Michael Graeber, MD (2) · Parviz Toossi, M.D. (2) · Raja K Sivamani, MD (2) · Raja Sivamani, MD MS AP (2) · Robert Bissonnette, MD (2) · Sabine Hazan, MD (2) · Tim Theisen (2) · Adelaide Hebert, MD (1) · Adele Sparavigna, Physician (1)
PMID 32886337, PMID 18720689, PMID 20214175, PMID 23547851, PMID 24934963, PMID 26293170, PMID 26897386, PMID 27177989, PMID 27514932, PMID 28573779, PMID 29027127, PMID 29369333, PMID 30296534, PMID 31896400, PMID 32038751, PMID 33150170, PMID 33760691, PMID 34478863, PMID 35483736, PMID 35789996, PMID 36698447, PMID 36946749, PMID 37998335, PMID 38034535, PMID 38912192, PMID 39066638, PMID 39529772, PMID 40321085
2025 (2), 2023 (1), U01AR079752 (1)